• In early January, research analysts at Mizuho Securities and Maxim Group updated their views on Herbalife, citing a turnaround narrative, improved supply chain ties with distributors, and the resolution of prior US regulatory concerns.
• This shift in external commentary highlights how regulatory clarity and tighter distributor relationships are shaping perceptions of Herbalife’s long-term business model and risk profile.
• With analysts pointing to regulatory issues being resolved, we’ll now examine how this development reshapes Herbalife’s existing investment narrative and outlook.

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 38 companies in the world exploring or producing it. Find the list for free.

Herbalife Investment Narrative Recap

To own Herbalife, you need to believe its direct selling model can keep generating steady demand for nutrition and wellness products while managing regulatory and distributor-related risks. The latest analyst updates, which reference resolved US regulatory concerns and tighter distributor ties, support the near term turnaround narrative but do not materially change the key catalyst of improving sales trends or the central risk around the resilience and quality of its distributor network.

Against this backdrop, the upcoming Q4 2025 earnings release on 18 February 2026 is especially relevant, as it will show whether early signs of momentum and recent product and technology investments are translating into consistent sales growth and healthier profitability.

Yet behind the improving sentiment and product pipeline, there remains a material distributor network risk that investors should be aware of...

Herbalife’s narrative projects $5.6 billion revenue and $152.6 million earnings by 2028. This implies 4.4% yearly revenue growth and a $172.4 million earnings decrease from $325.0 million today.

Uncover how Herbalife's forecasts yield a $14.00 fair value, a 18% downside to its current price.

Exploring Other Perspectives

Nine fair value estimates from the Simply Wall St Community span a wide range, from as low as US$2.06 up to about US$24.72 per share. When you weigh those views against the company’s dependence on a stable, engaged distributor base, it underlines how differently people assess Herbalife’s ability to sustain its business model and earnings power over time.

Explore 9 other fair value estimates on Herbalife - why the stock might be worth less than half the current price!

Build Your Own Herbalife Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Herbalife research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Herbalife research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Herbalife's overall financial health at a glance.

Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• Outshine the giants: these 24 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.